TTK Healthcare Reports Revenue Growth Amidst Profit Dip for FY26

TTK Healthcare Limited's revenue increased by 7% to ₹857.28 crore for the year ended March 31, 2026, compared to ₹801.49 crore in the previous fiscal. However, the company's Profit After Tax (PAT) saw a 20% decline, dropping to ₹65.68 crore from ₹81.65 crore in FY25.

Reader Takeaway: Revenue growth is positive, but profit pressure from exceptional charges needs monitoring.

What just happened

The company announced its audited financial results for the fiscal year ending March 31, 2026. Revenue from operations grew to ₹857.28 crore, up from ₹801.49 crore in the prior year. Net profit, however, decreased to ₹65.68 crore from ₹81.65 crore, impacted by exceptional items.

Why this matters

While top-line growth is a good sign, the decline in profitability raises concerns about margin management. The recommended dividend signals confidence in future cash flows, but investors will be keen to understand the sustainability of profits.

The backstory

For the year ended March 31, 2026, TTK Healthcare Limited has declared its audited results. The company operates across various segments including Animal Welfare, Consumer Products, Medical Devices, Protective Devices, and Foods. The previous fiscal year (FY25) saw revenues of ₹801.49 crore and a PAT of ₹81.65 crore.

What changes now

The board has recommended a dividend of ₹10 per equity share (100%), subject to shareholder approval. T T Raghunathan has been reappointed as Executive Chairman for a further five-year term from November 1, 2026. The company also appointed M/s Geeyes & Co. as the Cost Auditor for FY 2026-27.

Risks to watch

The company's profitability was affected by a net charge of ₹7.58 crore related to Labour Codes (Gratuity and Long-term Compensated Absences) in Q3 FY26 and an exceptional income of ₹3.50 crore from a GST refund in Q4 FY26. Future performance might be influenced by the ongoing impact of these labor code provisions and potential cost adjustments.

Segment Performance

• Animal Welfare: Revenue ₹141.08 crore, Profit ₹11.92 crore.
• Consumer Products: Revenue ₹241.28 crore, Profit ₹18.35 crore.
• Medical Devices: Revenue ₹106.92 crore, Profit ₹22.54 crore.
• Protective Devices: Revenue ₹216.51 crore, a Loss of ₹10.54 crore.
• Foods: Revenue ₹151.10 crore, Profit ₹13.43 crore.

Context metrics (time-bound)

• Revenue Growth: 7% increase for FY 2025-26 compared to FY 2024-25.
• Profit Decline: 20% decrease in PAT for FY 2025-26 compared to FY 2024-25.
• Dividend: ₹10 per equity share (100%) recommended for FY 2025-26.

What to track next

Investors will be watching how TTK Healthcare manages its costs, particularly in relation to the Labour Codes, and its impact on the bottom line in the upcoming fiscal year. The performance of the Protective Devices segment, which reported a loss, will also be under scrutiny.